Related references
Note: Only part of the references are listed.Screening Examination of Premature Infants for Retinopathy of Prematurity
Walter M. Fierson
PEDIATRICS (2018)
The Efficacy of Propranolol in Retinopathy of Prematurity and its Correlation with the Platelet Mass Index
Levent Korkmaz et al.
CURRENT EYE RESEARCH (2017)
Propranolol 0.1% eye micro-drops in newborns with retinopathy of prematurity: a pilot clinical trial
Luca Filippi et al.
PEDIATRIC RESEARCH (2017)
Treatment trends for retinopathy of prematurity in the UK: active surveillance study of infants at risk
Gillian G. W. Adams et al.
BMJ OPEN (2017)
Prophylactic propranolol for prevention of ROP and visual outcome at 1 year (PreROP trial)
Kishore Pratap Sanghvi et al.
ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION (2017)
Study protocol: safety and efficacy of propranolol 0.2% eye drops in newborns with a precocious stage of retinopathy of prematurity (DROP-ROP-0.2%): a multicenter, open-label, single arm, phase II trial
Luca Filippi et al.
BMC PEDIATRICS (2017)
Practice Patterns in Retinopathy of Prematurity Treatment for Disease Milder Than Recommended by Guidelines
Mrinali Patel Gupta et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2016)
Oral propranolol in early stages of retinopathy of prematurity
Aldo Bancalari et al.
JOURNAL OF PERINATAL MEDICINE (2016)
Interventions To Prevent Retinopathy of Prematurity: A Meta-analysis
Jennifer L. Fang et al.
PEDIATRICS (2016)
Pharmacologic interventions for the prevention and treatment of retinopathy of prematurity
Kay D. Beharry et al.
SEMINARS IN PERINATOLOGY (2016)
Compound 49b Restores Retinal Thickness and Reduces Degenerate Capillaries in the Rat Retina following Ischemia/Reperfusion
Li Liu et al.
PLOS ONE (2016)
NATURAL HISTORY OF RETINOPATHY OF PREMATURITY Two-Year Outcomes of a Prospective Study
Yi-Hsing Chen et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2015)
Protective Effects of β1/2 Adrenergic Receptor Deletion in a Model of Oxygen-Induced Retinopathy
Massimo Dal Monte et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2015)
Infantile Hemangiomas, Retinopathy of Prematurity and Cancer: A Common Pathogenetic Role of the β-Adrenergic System
Luca Filippi et al.
MEDICINAL RESEARCH REVIEWS (2015)
The pathophysiology of retinopathy of prematurity: an update of previous and recent knowledge
Giacomo Cavallaro et al.
ACTA OPHTHALMOLOGICA (2014)
Pharmacokinetics and local safety profile of propranolol eye drops in rabbits
Letizia Padrini et al.
PEDIATRIC RESEARCH (2014)
Oral propranolol versus placebo for retinopathy of prematurity: a pilot, randomised, double-blind prospective study
Imad R. Makhoul et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2013)
Eye drop propranolol administration promotes the recovery of oxygen-induced retinopathy in mice
Massimo Dal Monte et al.
EXPERIMENTAL EYE RESEARCH (2013)
Propranolol concentrations after oral administration in term and preterm neonates
L. Filippi et al.
JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE (2013)
Oral Propranolol for Retinopathy of Prematurity: Risks, Safety Concerns, and Perspectives
Luca Filippi et al.
JOURNAL OF PEDIATRICS (2013)
A rapid liquid chromatography tandem mass spectrometry-based method for measuring propranolol on dried blood spots
Maria Luisa Della Bona et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2013)
Beta3-adrenergic receptors modulate vascular endothelial growth factor release in response to hypoxia through the nitric oxide pathway in mouse retinal explants
Massimo Dal Monte et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2013)
Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010
Hannah Blencowe et al.
PEDIATRIC RESEARCH (2013)
Beta-Adrenoreceptor Agonism Influences Retinal Responses to Hypoxia in a Model of Retinopathy of Prematurity
Massimo Dal Monte et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2012)
Antiangiogenic effects of β2-adrenergic receptor blockade in a mouse model of oxygen-induced retinopathy
Davide - Martini et al.
JOURNAL OF NEUROCHEMISTRY (2011)
Role of the Adrenergic System in a Mouse Model of Oxygen-Induced Retinopathy: Antiangiogenic Effects of beta-Adrenoreceptor Blockade
Chiara Ristori et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2011)
Application of isoproterenol inhibits diabetic-like changes in the rat retina
Youde Jiang et al.
EXPERIMENTAL EYE RESEARCH (2010)
Hyperoxia disrupts vascular endothelial growth factor-nitric oxide signaling and decreases growth of endothelial colony-forming cells from preterm infants
Hideshi Fujinaga et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2009)
The incidence and course of retinopathy of prematurity: Findings from the early treatment for retinopathy of prematurity study
WV Good
PEDIATRICS (2005)
The international classification of retinopathy of prematurity revisited
GA Gole et al.
ARCHIVES OF OPHTHALMOLOGY (2005)
Redox-dependent effects of nitric oxide on microvascular integrity in oxygen-induced retinopathy
MH Beauchamp et al.
FREE RADICAL BIOLOGY AND MEDICINE (2004)
Nitric oxide is proangiogenic in the retina and choroid
A Ando et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2002)
Share Paper
